- Title
- S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3
- Creators
- Valeria Santini - University of FlorenceUwe Platzbecker - University Hospital LeipzigPierre Fenaux - Hôpital Saint-LouisMikkael Sekeres - University of MiamiMichael Robert Savona - Vanderbilt University Medical CenterYazan Madanat - The University of Texas Southwestern Medical CenterMaría Díez Campelo - Hematology Department, The University Hospital of Salamanca, Salamanca, SpainDavid Valcárcel - Hospital Universitari Vall d'HebronThomas Illmer - Hematology Private Practice, Dresden, GermanyAnna Jonášová - 1st Medical Department - Hematology, General Hospital, Prague, Czech RepublicPetra Belohlavkova - University Hospital Hradec KrálovéLaurie Sherman - GeronTymara Berry - GeronSouria Dougherty - GeronSheetal Shah - GeronQi Xia - GeronLixian Peng - GeronLibo Sun - GeronYing Wan - GeronFei Huang - GeronAnnat Ikin - GeronShyamala Navada - GeronFaye Feller - GeronAmer M. Zeidan - University of New HavenRami S. Komrokji - Moffitt Cancer Center
- Publication Details
- HemaSphere, Vol.7(Suppl)
- Publisher
- Lippincott Williams & Wilkins
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031926774302976
Journal article
S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3
HemaSphere, Vol.7(Suppl)
2023-08-08
Metrics
1 Record Views